Superoxide anion and nitric oxide in high-grade esophagitis induced by acid and pepsin in rabbits.
It has been proposed that free radicals are involved in the pathogenesis of esophageal mucosal damage induced by acid and pepsin. Recent data have suggested that nitric oxide (NO) is involved in the mucosal defense of the esophagus and that superoxide anion plays a minor role in low-grade esophagitis. To study the role and potential interaction of NO and superoxide anion in an experimental model of high-grade esophagitis, acidified pepsin was perfused (45 min/12 hr) for five days in rabbits with different agents to modulate the generation of these radicals. Measurements included both macroscopic and microscopic mucosal damage, superoxide anion generation, NO synthase mucosal activity, and peroxynitrite formation. High-grade esophagitis was associated with mucosal superoxide anion generation. Treatment with exogenous superoxide dismutase completely prevented mucosal damage. The perfusion of acidified pepsin in the lumen of the esophagus was initially associated with increased NO synthase mucosal activity but decreased with the progression of damage. Generation of peroxynitrites was present in those cases with severe damage. Treatment with NO-modifying agents did not induce consistent modification of mucosal damage. It is concluded that superoxide anion is involved in the induction of high-grade esophagitis and that it interacts with nitric oxide to generate peroxynitrite radicals in this model. Superoxide dismutase but not NO-donor-modifying agents might have a therapeutic role in preventing severe esophageal mucosal damage induced by acid and pepsin.
Lanas
A
A
Service of Gastroenterology, University Hospital and University of Zaragoza, Spain.
Soteras
F
F
Jimenez
P
P
Fiteni
I
I
Piazuelo
E
E
Royo
Y
Y
Ortego
J
J
Iñarrea
P
P
Esteva
F
F
D000818:Animals; D004941:Esophagitis / Q000378:metabolism* / Q000473:pathology; D004947:Esophagus / Q000473:pathology; D006801:Humans; D009092:Mucous Membrane / Q000473:pathology; D016877:Oxidants / Q000378:metabolism*; D011817:Rabbits; D013482:Superoxide Dismutase / Q000378:metabolism / Q000627:therapeutic use; D013481:Superoxides / Q000378:metabolism*
D016877:Oxidants; D013481:Superoxides; D013482:Superoxide Dismutase